Citigroup’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.16M | Sell |
|
|||||
|
2025
Q2 | $23.2M | Sell |
|
|||||
|
2025
Q1 | $19.9M | Buy |
|
|||||
|
2024
Q4 | $712K | Buy |
|
|||||
|
2024
Q3 | $516K | Buy |
|
|||||
|
2024
Q2 | $265K | Sell |
|
|||||
|
2024
Q1 | $1.78M | Buy |
|
|||||
|
2023
Q4 | $77.5K | Sell |
|
|||||
|
2023
Q3 | $631K | Buy |
|
|||||
|
2023
Q2 | $687K | Sell |
|
|||||
|
2023
Q1 | $1.41M | Buy |
|
|||||
|
2022
Q4 | $1.06M | Sell |
|
|||||
|
2022
Q3 | $1.81M | Buy |
|
|||||
|
2022
Q2 | $839K | Buy |
|
|||||
|
2022
Q1 | $237K | Sell |
|
|||||
|
2021
Q4 | $1.32M | Buy |
|
|||||
|
2021
Q3 | $612K | Sell |
|
|||||
|
2021
Q2 | $1.99M | Sell |
|
|||||
|
2021
Q1 | $2.46M | Buy |
|
|||||
|
2020
Q4 | $152K | Buy |
|
|||||
|
2020
Q3 | $47K | Sell |
|
|||||
|
2020
Q2 | $662K | Sell |
|
|||||
|
2020
Q1 | $587K | Sell |
|
|||||
|
2019
Q4 | $829K | Buy |
|
|||||
|
2019
Q3 | $1.21M | Buy |
|
|||||
|
2019
Q2 | $1.7M | Buy |
|
|||||
|
2019
Q1 | $91K | Sell |
|
|||||
|
2018
Q4 | $7.23M | Buy |
|
|||||
|
2018
Q3 | $4.21M | Sell |
|
|||||
|
2018
Q2 | $3.63M | Sell |
|
|||||
|
2018
Q1 | $9.21M | Sell |
|
|||||
|
2017
Q4 | $13.4M | Buy |
|
|||||
|
2017
Q3 | $4.29M | Buy |
|
|||||
|
2017
Q2 | $44K | Buy |
|
|||||
|
2017
Q1 | $4K | Buy |
|